Literature DB >> 7826342

Changes in calcium influx affect the differentiation of murine erythroleukaemia cells.

B Sparatore1, A Pessino, M Patrone, M Passalacqua, E Melloni, S Pontremoli.   

Abstract

As indicated by direct evidence, obtained by altering the cell-membrane permeability for Ca2+ in murine erythroleukaemia (MEL) cells, calpain is the triggering factor which connects fluctuations of the intracellular Ca2+ concentrations to the decay of protein kinase C (PKC), as well as to the kinetics of cell differentiation induced by hexamethylenebisacetamide. Cell exposure to verapamil caused a profound decrease in the rate of PKC down-regulation and a slower initial rate of accumulation of mature erythroid cells, whereas addition of the Ca2+ ionophore A23187 produced opposite effects. The high susceptibility of PKC-delta to calpain degradation, at concentrations of Ca2+ much lower than those required for degradation of the other PKC isoforms, may be explained by the finding that this kinase isoform is predominantly associated with the cell membrane. The different cellular localizations, as well as the different susceptibilities to calpain digestion, further support the hypothesis that in MEL cells the various PKC isoforms play distinct biological functions that are critical for the maintenance of the undifferentiated state of the cell and for its commitment to terminal erythroid differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7826342      PMCID: PMC1136461          DOI: 10.1042/bj3050285

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase C.

Authors:  S Pontremoli; E Melloni; G Damiani; F Salamino; B Sparatore; M Michetti; B L Horecker
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

2.  A procedure to introduce protein molecules into living mammalian cells.

Authors:  S Nomura; T Kamiya; M Oishi
Journal:  Exp Cell Res       Date:  1986-04       Impact factor: 3.905

3.  Protein kinase C zeta isoform is critical for mitogenic signal transduction.

Authors:  E Berra; M T Diaz-Meco; I Dominguez; M M Municio; L Sanz; J Lozano; R S Chapkin; J Moscat
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

4.  Measurement of changes in cellular calcium metabolism in response to thyrotropin-releasing hormone.

Authors:  E Geras-Raaka; M C Gershengorn
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 5.  Protein kinase C--a question of specificity.

Authors:  L V Dekker; P J Parker
Journal:  Trends Biochem Sci       Date:  1994-02       Impact factor: 13.807

6.  Role of delta-PKC on the differentiation process of murine erythroleukemia cells.

Authors:  B Sparatore; A Pessino; M Patrone; M Passalacqua; E Melloni; S Pontremoli
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

7.  Differences in the effects of phorbol esters and diacylglycerols on protein kinase C.

Authors:  M D Bazzi; G L Nelsestuen
Journal:  Biochemistry       Date:  1989-11-28       Impact factor: 3.162

8.  Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation.

Authors:  E Melloni; S Pontremoli; P L Viotti; M Patrone; P A Marks; R A Rifkind
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

9.  Protein kinase C isoforms in murine erythroleukemia cells and their involvement in the differentiation process.

Authors:  M Patrone; A Pessino; M Passalacqua; B Sparatore; E Melloni; S Pontremoli
Journal:  FEBS Lett       Date:  1994-05-09       Impact factor: 4.124

10.  Introduction of the beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells.

Authors:  E Melloni; S Pontremoli; B Sparatore; M Patrone; F Grossi; P A Marks; R A Rifkind
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

View more
  2 in total

1.  Drug-mediated inhibition of Fli-1 for the treatment of leukemia.

Authors:  Y-J Li; X Zhao; L M Vecchiarelli-Federico; Y Li; A Datti; Y Cheng; Y Ben-David
Journal:  Blood Cancer J       Date:  2012-01-27       Impact factor: 11.037

2.  Hexamethylene bisacetamide impairs NK cell-mediated clearance of acute T lymphoblastic leukemia cells and HIV-1-infected T cells that exit viral latency.

Authors:  Erica Giuliani; Maria Giovanna Desimio; Margherita Doria
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.